Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KX Antihypertensives for pulmonary arterial hypertension
C02KX54 Macitentan and tadalafil
D12963 Macitentan and tadalafil <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Pulmonary Antihypertensives
Prostacyclin Vasodilators
Macitentan/ Tadalafil
D12963 Macitentan and tadalafil
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D12963 Macitentan and tadalafil
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D12963 Macitentan and tadalafil
DG01642 CYP2C9 substrate
D12963 Macitentan and tadalafil
DG01639 CYP2C19 substrate
D12963 Macitentan and tadalafil
DG01633 CYP3A/CYP3A4 substrate
D12963 Macitentan and tadalafil
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12963
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12963
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D12963